Pharmacokinetics of Amoxicillin: Dose Dependence After Intravenous, Oral, and Intramuscular Administration

Amoxicillin was studied in normal subjects after intravenous, oral, and intramuscular administration of 250-, 500-, and 1,000-mg doses. Serum drug levels were analyzed using a two-compartment open model, as well as area under the curve (AUC) and urinary recovery. The variations of these pharmacokinetic parameters were then examined using the three-way analysis of variance and linear regression equations. These results confirmed nearly complete oral absorption: AUC was 93% of intravenous absorption, and urinary recovery was 86%. The intramuscular administration of amoxicillin results in complete and reliable absorption with peak drug levels, AUCs, and urinary recovery equivalent to oral dosage. The absorption of lyophilized amoxicillin after intramuscular injection resulted in an AUC that was 92% of intravenous absorption and urinary recovery of 91%. The peak serum levels, time to peak, and other pharmacokinetic parameters for intramuscular injection were nearly identical to those for oral administration. Kinetics of both intramuscular and oral administration exhibited dose-dependent absorption (absorption rate constant, 1.3/h for 250 mg and 0.7/h for 1,000 mg). This resulted in relatively later and lower peak serum levels for increasing dose. Total absorption, however, showed no dose dependence, as indicated by urinary recovery and AUC, which changed by less than 10%.

[1]  J. Wagner,et al.  Per cent absorbed time plots derived from blood level and/or urinary excretion data. , 1963, Journal of pharmaceutical sciences.

[2]  Milton Abramowitz,et al.  Handbook of Mathematical Functions with Formulas, Graphs, and Mathematical Tables , 1964 .

[3]  F. Watanabe,et al.  Pharmacological studies of 6 (D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid in humans. , 1964 .

[4]  L. Hollister,et al.  INTER- AND INTRASUBJECT VARIATIONS IN DRUG ABSORPTION KINETICS. , 1964, Journal of pharmaceutical sciences.

[5]  J. Wagner,et al.  KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG. , 1964, Journal of pharmaceutical sciences.

[6]  E. Benner,et al.  Simplified, accurate method for antibiotic assay of clinical specimens. , 1966, Applied microbiology.

[7]  M. Rowland,et al.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. , 1968, Journal of pharmaceutical sciences.

[8]  F. James Rohlf,et al.  Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .

[9]  K. Bischoff,et al.  Generalized solution to linear, to-compartment, open model for drug distribution. , 1970, Journal of theoretical biology.

[10]  H. Neu,et al.  Pharmacological studies of 6 (D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid in humans. , 1970, Antimicrobial agents and chemotherapy.

[11]  In vitro antimicrobial activity of 6(D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid, a new semisynthetic penicillin. , 1970, Antimicrobial agents and chemotherapy.

[12]  D. A. Spyker Simulation in the analysis and control of a cardio-circulatory assist device , 1970 .

[13]  John A. Nelder,et al.  Statistics In Biology. , 1971 .

[14]  W. M. Kirby,et al.  Comparative Clinical Pharmacology of Amoxicillin and Ampicillin Administered Orally , 1972, Antimicrobial Agents and Chemotherapy.

[15]  Trial of a new broad-spectrum penicillin (amoxycillin) in general practice. , 1972, The Practitioner.

[16]  D. Leigh Diagnosis of urinary tract infections in general practice, and treatment with a new penicillin--amoxycillin. , 1972, Current medical research and opinion.

[17]  Trial of a new broad-spectrum penicillin (amoxycillin) in general practice. , 1972 .

[18]  G. Bodey,et al.  Amoxicillin: In Vitro and Pharmacological Studies , 1972, Antimicrobial Agents and Chemotherapy.

[19]  A. Wilensky,et al.  Inadequate serum levels after intramuscular administration of diphenylhydantoin , 1973, Neurology.

[20]  D. M. Hailey,et al.  Plasma levels of diazepam and its major metabolite following intramuscular administration. , 1973, British journal of anaesthesia.

[21]  K. Holmes,et al.  Amoxicillin, a New Penicillin Antibiotic , 1973, Antimicrobial Agents and Chemotherapy.

[22]  Preliminary clinical study with amoxycillin (BRL 2333) in complicated lower respiratory tract infections. , 1973, Chemotherapy.

[23]  Clinical experience of amoxycillin in the United Kingdom. , 1973, Chemotherapy.

[24]  B. Wilder,et al.  Plasma diphenylhydantoin values after oral and intramuscular administration of diphenylhydantoin , 1973, Neurology.

[25]  Clinical and Laboratory Evaluation of Amoxicillin (BRL 2333) in the Treatment of Urinary Tract Infections , 1973, Antimicrobial Agents and Chemotherapy.

[26]  D. Greenblatt,et al.  Drug therapy. Benzodiazepines (first of two parts). , 1974 .

[27]  M. J. Griffiths,et al.  Amoxycillin: A new Semi-synthetic Penicillin , 1972, British medical journal.

[28]  D. Höffler [The pharmacokinetics of amoxicillin]. , 1974, Advances in clinical pharmacology.

[29]  L. Sabath,et al.  Sequence Effect on Ampicillin Blood Levels Noted in an Amoxicillin, Ampicillin, and Epicillin Triple Crossover Study , 1975, Antimicrobial Agents and Chemotherapy.

[30]  D. Greenblatt,et al.  Clinical pharmacokinetics (second of two parts). , 1975, The New England journal of medicine.

[31]  Just how good is amoxicillin? , 1975, Medical times.

[32]  D. Greenblatt,et al.  Drug therapy. Clinical Pharmacokinetics (first of two parts). , 1975 .